| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 02/14/2008 | US20080039622 2,4-pyrimidinediamine compounds and their uses |
| 02/14/2008 | US20080039513 Marine Compounds with Calcium Channel Blocking Properties for the Treatment of Cognitive or Neurodegenerative Diseases |
| 02/14/2008 | US20080039502 e.g. N-[4-(4'-Methoxy-biphenyl-4-yloxymethyl)-5-methyl-furan-2-carbonyl]-benzenesulfonamide; prostaglandin E4 receptor antagonist; analgesic, antiinflammatory agent; migraines and headache |
| 02/14/2008 | US20080039472 Inhibitors of the Interaction Between Mdm2 and P53 |
| 02/14/2008 | US20080039465 Triazolyl phenyl benzenesulfonamides |
| 02/14/2008 | US20080039464 Compounds Which Modulate The CB2 Receptor |
| 02/14/2008 | US20080039462 Compounds having 5-HT6 receptor affinity |
| 02/14/2008 | US20080039459 Phosphoinositide 3-kinase inhibitor compounds and methods of use |
| 02/14/2008 | US20080039454 Urotensin II receptor antagonists |
| 02/14/2008 | US20080039450 Compounds |
| 02/14/2008 | US20080039449 [1,4]benzodiazepine derivatives, used for treating osteoarthritis, pancreatitis, glomerulonephritis, rheumatoid arthritis, inflammatory bowel disease, Crohn's disease, psoriasis, graft vs host disease, leukemia, septic shock, multiple sclerosis, and inflammatory bowel disease |
| 02/14/2008 | US20080039447 CDK-Inhibitory pyrimidines, their production and use as pharmaceutical agents |
| 02/14/2008 | US20080039446 Substituted isoindoles and their use |
| 02/14/2008 | US20080039442 Compounds With Kv4 Ion Channel Activity |
| 02/14/2008 | US20080039440 such as 6-(6-Amino-pyrimidin-4-yloxy)-3,4-dihydro-2H-quinoline-1-carboxylic acid (3-trifluoromethyl-phenyl)-amide, used for the treatment of leukemia |
| 02/14/2008 | US20080039437 New Pyridine Analogues III |
| 02/14/2008 | US20080039377 Composition Comprising a Jnk Inhibitor and Cyclosporin |
| 02/14/2008 | US20080039327 3-heterocyclyl-substituted benzoyl derivatives |
| 02/14/2008 | DE102006037478A1 2-(Heterocyclylbenzyl)-pyridazinonderivate 2- (Heterocyclylbenzyl) -pyridazinone derivatives |
| 02/14/2008 | CA2660538A1 Nitrate esters of piperidines |
| 02/14/2008 | CA2660421A1 1h-quinolin-4-one compounds, with affinity for the gaba receptor, processes, uses and compositions |
| 02/14/2008 | CA2660349A1 2-aminobenzoxazole carboxamides as 5ht3 modulators |
| 02/14/2008 | CA2660195A1 2-(heterocyclylbenzyl)pyridazinone derivatives |
| 02/14/2008 | CA2660192A1 Novel enantiomeric pure beta agonists, method of manufacture and use as a medicament thereof |
| 02/14/2008 | CA2659884A1 Processes for the preparation of n-(2-acetyl-4,6-dimethylphenyl)-3-{[(3,4 dimethyl-5-isoxazolyl)amino}sulfonyl}-2-thiophenecarboxamide |
| 02/14/2008 | CA2659811A1 Polymorphs of n-(2-acetyl-4,6-dimethylphenyl)-3-{[(3,4 dimethyl-5-isoxazolyl)-amino]sulfonyl}-2-thiophene-carboxamide |
| 02/13/2008 | EP1887005A1 Processes for production of optically active ppar-activating compounds and intermediates for production thereof |
| 02/13/2008 | EP1887002A1 Carboxamide compound and use thereof |
| 02/13/2008 | EP1886996A1 1H-Quinolin-4-one compounds, with affinity for the GABA receptor, processes, uses and compositions |
| 02/13/2008 | EP1886994A1 Cyclic amine compounds as CCR5 antagonists |
| 02/13/2008 | EP1885718A1 Fluorescent chemical compounds having high selectivity for double stranded dna, and methods for their use |
| 02/13/2008 | EP1885695A2 Novel indoline compounds |
| 02/13/2008 | EP1480973B1 1,4-disubstituted benzofused cycloalkyl urea compounds useful in treating cytokine mediated diseases |
| 02/13/2008 | EP1463716B1 Pyrrolidine and piperidine derivates as nk1 antagonists |
| 02/13/2008 | EP1335908B1 Peroxisome proliferator activated receptor alpha agonists |
| 02/13/2008 | CN101124222A Tetrahydroquinoline analogues as muscarinic agonists |
| 02/13/2008 | CN101124217A CGRP receptor antagonists |
| 02/13/2008 | CN101124203A Chemical compounds |
| 02/13/2008 | CN101124201A Parp抑制剂 Parp inhibitors |
| 02/13/2008 | CN101121712A Heterocycle-containing cinnamenylcoumarin derivatives and synthesizing method thereof |
| 02/13/2008 | CN100368415C 6-alkenyl-, 6-alkinyl-and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations |
| 02/12/2008 | US7329765 Benzothiophene compounds having antiinfective activity |
| 02/12/2008 | US7329756 Process for the manufacture of Isradipine |
| 02/12/2008 | US7329750 17-Acetamido-4-azasteroid derivatives as androgen receptor modulators |
| 02/12/2008 | US7329685 1-Phenyl-2-oxo-3-sulfonylamino-pyrrolidine derivatives and related compounds as factor Xa inhibitors for the treatment of acute vascular diseases |
| 02/12/2008 | US7329681 Inhibitors of IMPDH enzyme |
| 02/12/2008 | US7329675 Substituted azabicyclic compounds |
| 02/12/2008 | US7329672 N4-(1,4-Benzoxazin-6-yl)-5-fluoro-N2-[3-(N-methylamino)carbonylmethyleneoxyphenyl]-2,4-pyrimidinediamine or a salt, hydrate, solvate and/or N-oxide; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors |
| 02/12/2008 | US7329671 N2,N4-bis(3-hydroxyphenyl)-5-fluoro-2,4-pyrimidinediamine or a salt, hydrate, solvate and/or N-oxide; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors |
| 02/12/2008 | US7329659 Substituted-1-phthalazinamines as vr-1 antagonists |
| 02/12/2008 | US7329656 Arylthiobenzylpiperidine derivatives |
| 02/12/2008 | US7329655 Drugs that inhibit phosphorylation kinases as an antigrowth or antiproliferation agent |
| 02/12/2008 | US7329652 Janus Kinase JAK2 and JAK3; 4-chloro-6-(3,5-dimethylpiperazin-1-yl)pyrimidine; chemotherapeutic, antiproliferative, antiinflammatory, immunomodulatory agent; allergies, asthma, autoimmune diseases, transplant rejection, rheumatoid arthritis, multiple sclerosis |
| 02/12/2008 | US7329427 Catalytic hydrogenation; artificial sweetener |
| 02/12/2008 | CA2374737C Novel process for synthesis of heteroaryl-substituted urea compounds |
| 02/12/2008 | CA2315261C Oral pharmaceutical extended release dosage form |
| 02/12/2008 | CA2290992C (imidazol-5-yl)methyl-2-quinolinone derivatives as inhibitors of smooth muscle cell proliferation |
| 02/12/2008 | CA2220140C (2-morpholinylmethyl)benzamide derivatives |
| 02/12/2008 | CA2197467C Method for the preparation of taxol and its derivatives |
| 02/07/2008 | WO2008016973A1 2,4-diaminoquinazolines for spinal muscular atrophy |
| 02/07/2008 | WO2008016175A1 Activator for peroxisome proliferator activated receptor |
| 02/07/2008 | WO2008016139A1 Fluorescent oleamide derivative and use thereof |
| 02/07/2008 | WO2008015693A2 Process for the preparation of mycophenolate mofetil |
| 02/07/2008 | WO2008015266A1 Substituted dimethylcyclobutyl compounds, their preparation and use in medicaments |
| 02/07/2008 | WO2008015189A2 Fungicidal n-cycloalkyl-carboxamide derivatives |
| 02/07/2008 | WO2008014822A1 6-1h-imidazo-quinazoline and quinolines derivatives, new potent analgesics and anti-inflammatory agents |
| 02/07/2008 | WO2008014602A1 Quinoline derivatives |
| 02/07/2008 | WO2007146550A3 Alkene piperidine derivatives as antiviral agents |
| 02/07/2008 | WO2007136300A3 Substituted indoles and a method for the production and use thereof |
| 02/07/2008 | WO2007121484A3 6-o-substituted benzoxazole and benzothiazole compounds and methods of inhibiting csf-1r signaling |
| 02/07/2008 | US20080033170 Novel compounds |
| 02/07/2008 | US20080033165 2-(3-(2-phenyloxazolidin-4-on-3-yl)-4-(2-styryl)-azetidin-2-on-1-yl) alkanedioic acid derivatives and corresponding alkoxyalkanoic acid derivatives; treating psychological disorders, cardiovascular disorders |
| 02/07/2008 | US20080032996 Substituted Quinazoline or Pyridopyrimidine Derivative |
| 02/07/2008 | US20080032995 Aldh-2 inhibitors in the treatment of drug addiction |
| 02/07/2008 | US20080032980 1-Carbonyl-3,5-diphenyl-4,5-dihydro-1H-pyrazoles such as 1-acetyl-4-(1-{[3-(2,5-difluorophenyl)-5-methyl-5-phenyl-4,5-dihydro-1H-pyrazol-1-yl]carbonyl}propyl)piperazine trifluoroacetate that are useful for treating cancer |
| 02/07/2008 | US20080032979 Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinease Inhibitors |
| 02/07/2008 | US20080032978 Soluble epoxide hydrolase inhibitors |
| 02/07/2008 | US20080032976 Histamine 3 receptor antagonists and/or inverse agonists; for obesity, metabolic syndrome (syndrome X), and other eating disorders; (4-cyclopentyl-piperazin-1-yl)-[3-(1-isopropyl-piperidin -4-yl)-l H-indol-6-yl]-methanone |
| 02/07/2008 | US20080032975 Substituted Fused Pyrroleoximes and Fused Pyrazoleoximes |
| 02/07/2008 | US20080032974 Compounds and therapeutical use thereof |
| 02/07/2008 | US20080032973 2-Quinazolinone compounds and methods of use |
| 02/07/2008 | US20080032972 Pyridopyrazines and derivatives thereof as alk and c-Met inhibitors |
| 02/07/2008 | US20080032971 8-heteroarylpurine mnk2 inhibitors for treating metabolic disorders |
| 02/07/2008 | US20080032970 Amide Derivatives of 7-Amino-3-Phenyl-Dihydropyrimido[4,5-D]Pyrimidinones, Their Manufacture and Use as Pharmaceutical Agents |
| 02/07/2008 | US20080032969 Novel compounds |
| 02/07/2008 | US20080032967 1,4-Disubstituted Naphthalenes as Inhibitors of P38 Map Kinase |
| 02/07/2008 | US20080032964 Process for the synthesis of azetidinone |
| 02/07/2008 | US20080032960 PI3 kinase antagonists |
| 02/07/2008 | CA2660028A1 Substituted dimethylcyclobutyl compounds, their preparation and use in medicaments |
| 02/07/2008 | CA2659696A1 6-1h-imidazo-quinazoline and quinolines derivatives, new potent analgesics and anti-inflammatory agents |
| 02/07/2008 | CA2659376A1 2,4-diaminoquinazolines for spinal muscular atrophy |
| 02/07/2008 | CA2658793A1 Quinoline derivatives |
| 02/07/2008 | CA2658479A1 Novel hiv reverse transcriptase inhibitors |
| 02/06/2008 | EP1884511A1 Aromatic ether compounds,preparation and usage thereof |
| 02/06/2008 | EP1883633A2 Heterocyclic anti-viral compounds comprising metabolizable moieties and their uses |
| 02/06/2008 | EP1883632A1 Vanilloid receptor ligands and their use in treatments |
| 02/06/2008 | EP1883302A2 Jak kinase inhibitors and their uses |
| 02/06/2008 | EP1845981A4 Synthesis of sodium narcistatin and related compounds |
| 02/06/2008 | CN101119992A Tricyclic delta-opioid modulators |
| 02/06/2008 | CN101119990A (1,5-diphenyl-1h-pyrazol-3-yl)oxadiazole derivatives, preparation method thereof and use of same in therapeutics |